Inspire Investing’s Ginkgo Bioworks DNA Stock Holding History

Inspire Investing’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$696K	Sell	70,246 -13,659	-16%	-$114K	0.03%	505
2026 Q1	$514K	Buy	83,905 +26,612	+46%	+$221K	0.03%	675
2025 Q4	$476K	Buy	57,293 +25,716	+81%	+$277K	0.04%	342
2025 Q3	$460K	Buy	+31,577	New	+$378K	0.04%	375

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Inspire Investing's DNA Position: Q2 2026 in Review

Inspire Investing reduced its Ginkgo Bioworks (DNA) stake by 16% in Q2 2026, selling an estimated $114K and leaving 70,246 shares worth $696K. The position accounts for 0.03% of the portfolio, ranked #505.

Inspire Investing first reported a position in DNA in Q3 2025 and has held it in 4 quarters since. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Inspire Investing held 70,246 shares of Ginkgo Bioworks worth $696K as of Q2 2026.
Inspire Investing sold 13,659 Ginkgo Bioworks shares in Q2 2026, an estimated $114K.
Ginkgo Bioworks made up 0.03% of Inspire Investing's portfolio in Q2 2026, its #505 holding.
Inspire Investing first reported a position in Ginkgo Bioworks in Q3 2025 and has held it in 4 quarters since.
183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.